Active ingredient: Insulin glargine.
Indication: DM in adults, adolescents & childn ≥2 yr.
Dosage & Administration: SC Individualized dose. Administer once daily at the same time each day.
Switch from bid NPH insulin to Semglee Reduce 20-30% of daily dose of basal insulin during the 1st wk of treatment.
Switch from insulin glargine 300 u/mL to Semglee Reduce dose by approx 20%.
Product Highlight - Semglee
07 Apr 2022